Inura Pharmaceutical Private Limited
About Inura Pharmaceutical Private Limited
Data last updated:
Inura Pharmaceutical Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 March 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U33111WB2013PTC191108. Its GSTIN is 19AADCI2417H1ZP (West Bengal).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ashutosh Kumar and Nutan Pandey.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B M C 4/80 Block – C Bera Bari Ghoshpara Ground Floor P O R Gopalpur N 24 Pgns, Kolkata, West Bengal, India – 700136.
As per the financials filed for FY 2025, the company reported a revenue of ₹47.63 Lakh, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹17,597 (net margin 0.4%) and EBITDA of ₹39,076 (EBITDA margin 0.8%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Inura Pharmaceutical Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB M C 4/80 Block – C Bera Bari Ghoshpara Ground Floor P O R Gopalpur N 24 Pgns, Kolkata, West Bengal, India – 700136
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Inura Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Inura Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Inura Pharmaceutical Private Limited, buy the company report.
Financials of Inura Pharmaceutical Private Limited
FY 2025 filings availableInura Pharmaceutical Private Limited reported revenue of ₹47.63 Lakh (up 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 18% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA rose 266% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹39,076 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17,597 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Inura Pharmaceutical Private Limited, buy the company report.
Board of directors of Inura Pharmaceutical Private Limited
Inura Pharmaceutical has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashutosh Kumar | Director | 04 Mar 2013 | 13 Years 8 Months | Current |
| Nutan Pandey | Director | 04 Mar 2013 | 13 Years 8 Months | Current |
| Mamta Pandey Also directs: Dhanvantari Medicine & Equipments Private Limited | Director | 18 Sep 2021 | 5 Years 1 Months | Current |
| Mamta Kumar Also directs: Dhanvantari Medicine & Equipments Private Limited | Director | 12 Mar 2015 | 11 Years 8 Months | Current |
Peer comparison
Inura Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rathi Brothers Madras Limited | ₹47.65 Lakh (FY 2017) | -88.0% | Pune, Maharashtra, India | |||
| Gaur Shyam Enterprises Private Limited | ₹47.65 Lakh (FY 2025) | 14.0% | Kolkata, West Bengal, India | |||
| Arv Retails Private Limited | ₹47.64 Lakh (FY 2025) | 7.0% | Haillymandi, Haryana, India | |||
| Excellous Technologies Private Limited | ₹47.64 Lakh (FY 2025) | 23009.0% | Hyderabad, Telangana, India | |||
| SNL Mills Private Limited | ₹47.63 Lakh (FY 2025) | 25.0% | Kargahar, Bihar, India | |||
| Inura Pharmaceutical Private Limitedthis company | ₹47.63 Lakh (FY 2025) | ₹17,597 | 0.4% | 18.0% | Kolkata, West Bengal, India | |
| A & T Corporate Resources Private Limited | ₹47.63 Lakh (FY 2023) | -52.0% | Delhi, India | |||
| Dnyaraja Agro Farmers Producer Company Limited | ₹47.62 Lakh (FY 2025) | -5.0% | Nanded, Maharashtra, India | |||
| Unovet Pharma Private Limited | ₹47.61 Lakh (FY 2019) | -7.0% | Patna, Bihar, India | |||
| Gabasthi Agro Exports Private Limited | ₹47.6 Lakh (FY 2024) | 1395.0% | Karkala, Karnataka, India | |||
| Alpine Hatcheries Private Limited | ₹47.6 Lakh (FY 2024) | -67.0% | Assam, India |
To see the full peer comparison of Inura Pharmaceutical Private Limited, buy the company report.
Auditor
Inura Pharmaceutical Private Limited is audited by APP & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| APP & CO. | FY 2017 | 324073E |
Shareholding
The shareholding of Inura Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Inura Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Inura Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Inura Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Inura Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AADCI2417H1ZP | West Bengal | Active | 23 Aug 2020 |
To see the full GST registrations and return filing status of Inura Pharmaceutical Private Limited, buy the company report.
Recent activity
Inura Pharmaceutical Private Limited has 7 board changes on record since 2013: 4 appointments and 3 cessations. The latest: Mamta Pandey was appointed as Director on 18 Sep 2021.
Frequently asked questions
Inura Pharmaceutical is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 March 2013 (13+ years old) and is registered under CIN U33111WB2013PTC191108.
Inura Pharmaceutical has 4 current directors:
- Ashutosh Kumar - Director
- Nutan Pandey - Director
- Mamta Pandey - Director
- Mamta Kumar - Director
The latest financial statements of Inura Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Inura Pharmaceutical is 19AADCI2417H1ZP, registered in West Bengal.
The CIN (Corporate Identification Number) of Inura Pharmaceutical is U33111WB2013PTC191108. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inura Pharmaceutical was incorporated on 04 March 2013, making it 13+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Inura Pharmaceutical by revenue are Rathi Brothers Madras Limited, Gaur Shyam Enterprises Private Limited, Arv Retails Private Limited, Excellous Technologies Private Limited, SNL Mills Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Mamta Pandey was appointed as Director on 18 Sep 2021. Vivek Kumar ceased to be Director on 26 Aug 2021. Debi Kundu ceased to be Director on 05 Feb 2019. Inura Pharmaceutical has 7 board changes on record in total.
The registered office of Inura Pharmaceutical is at B M C 480 Block – C Bera Bari Ghoshpara Ground Floor P O R Gopalpur N 24 Pgns, Kolkata, West Bengal, India – 700136.
Inura Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Inura Pharmaceutical is compliant as of 14 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
